相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。First international workshop of the ATM and cancer risk group (4-5 December 2019)
Fabienne Lesueur et al.
FAMILIAL CANCER (2022)
Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis
Reiko Yoshida
BREAST CANCER (2021)
Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers
Angela Toss et al.
GENES (2021)
Germline Mutations in Other Homologous Recombination Repair-Related Genes Than BRCA1/2: Predictive or Prognostic Factors?
Laura Cortesi et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Hereditary pancreatic cancer
Kodai Abe et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)
Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis
Raffaella Casolino et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Homologous Recombination Deficiency: Cancer Predispositions and Treatment Implications
MingRen Toh et al.
ONCOLOGIST (2021)
Retroperitoneal leiomyosarcoma in a female patient with a germline splicing variant RAD51D c.904-2A > T: a case report
Mashu Futagawa et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2021)
Familial pancreatic cancer with PALB2 and NBN pathogenic variants: a case report
Kodai Abe et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2021)
Germline Pathogenic Variants in 7636 Japanese Patients With Prostate Cancer and 12 366 Controls
Yukihide Momozawa et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study
Tommy Nyberg et al.
EUROPEAN UROLOGY (2020)
Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer
A. G. Waks et al.
ANNALS OF ONCOLOGY (2020)
Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline
Panagiotis A. Konstantinopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
Joaquin Mateo et al.
LANCET ONCOLOGY (2020)
Homologous recombination deficiency status-based classification of high-grade serous ovarian carcinoma
Hisamitsu Takaya et al.
SCIENTIFIC REPORTS (2020)
BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ∼30,000 cases
Malwina Suszynska et al.
JOURNAL OF OVARIAN RESEARCH (2020)
Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets
Can-Bin Fang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA
Claudia Piombino et al.
JOURNAL OF ONCOLOGY (2020)
ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer
R. E. Miller et al.
ANNALS OF ONCOLOGY (2020)
Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic Adenocarcinoma
Siddhartha Yadav et al.
CLINICAL CANCER RESEARCH (2020)
PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective
Vera Loizzi et al.
ONCOLOGY LETTERS (2020)
NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation
Kai Miao et al.
NATURE COMMUNICATIONS (2020)
Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes
Keijiro Mizukami et al.
EBIOMEDICINE (2020)
Molecular Features and Clinical Management of Hereditary Gynecological Cancers
Arisa Ueki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate
Lenka Stolarova et al.
CELLS (2020)
The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor
Andreia Brandao et al.
CANCERS (2020)
Pan-cancer landscape of homologous recombination deficiency
Luan Nguyen et al.
NATURE COMMUNICATIONS (2020)
Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer
Matthew B. Yurgelun et al.
GENETICS IN MEDICINE (2019)
Subtypes in BRCA-mutated breast cancer
Ida Marie H. Sonderstrup et al.
HUMAN PATHOLOGY (2019)
The influence of BRCA2 mutation on localized prostate cancer
Renea A. Taylor et al.
NATURE REVIEWS UROLOGY (2019)
The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysis
Mok Oh et al.
PROSTATE (2019)
Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines
Piper Nicolosi et al.
JAMA ONCOLOGY (2019)
BRIP-1 germline mutation and its role in colon cancer: presentation of two case reports and review of literature
Mir Ali et al.
BMC MEDICAL GENETICS (2019)
Tumour lineage shapes BRCA-mediated phenotypes
Philip Jonsson et al.
NATURE (2019)
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
R. L. Coleman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Germline and somatic mutations of multi-gene panel in Chinese patients with epithelial ovarian cancer: a prospective cohort study
Wenhui Li et al.
JOURNAL OF OVARIAN RESEARCH (2019)
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
I. Ray-Coquard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer
Nana Weber-Lassalle et al.
BREAST CANCER RESEARCH (2019)
Inherited DNA-Repair Defects in Colorectal Cancer
Saud H. AlDubayan et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
PARP Inhibitors for the Treatment of Ovarian Cancer
Laura Cortesi et al.
CURRENT CANCER DRUG TARGETS (2018)
Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer
Chunling Hu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls
Yukihide Momozawa et al.
NATURE COMMUNICATIONS (2018)
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
K. Moore et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes
Chunling Hu et al.
JCO PRECISION ONCOLOGY (2018)
Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls
Jenna Lilyquist et al.
GYNECOLOGIC ONCOLOGY (2017)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
Helen Davies et al.
NATURE MEDICINE (2017)
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Mark Robson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Rad50 ATPase activity is regulated by DNA ends and requires coordination of both active sites
Rajashree A. Deshpande et al.
NUCLEIC ACIDS RESEARCH (2017)
Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer
Akira Hirasawa et al.
ONCOTARGET (2017)
Microhomology-mediated end joining: new players join the team
Hailong Wang et al.
CELL AND BIOSCIENCE (2017)
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer
Fergus J. Couch et al.
JAMA ONCOLOGY (2017)
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
Jie Sun et al.
CLINICAL CANCER RESEARCH (2017)
The Evolution, Functions and Applications of the Breast Cancer Genes BRCA1 and BRCA2
Claire M. Pfeffer et al.
CANCER GENOMICS & PROTEOMICS (2017)
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
Thomas P. Slavin et al.
NPJ BREAST CANCER (2017)
A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes
Saundra S. Buys et al.
CANCER (2017)
Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women
Allison W. Kurian et al.
JCO PRECISION ONCOLOGY (2017)
Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care
Ella R. Thompson et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Inherited Mutations in Women With Ovarian Carcinoma
Barbara M. Norquist et al.
JAMA ONCOLOGY (2016)
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population
Honglin Song et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Frequency of Mutations in Individuals With Breast Cancer Referred for BRCA1 and BRCA2 Testing Using Next-Generation Sequencing With a 25-Gene Panel
Nadine Tung et al.
CANCER (2015)
The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers
Helen Cavanagh et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2015)
Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas
Kathryn P. Pennington et al.
CLINICAL CANCER RESEARCH (2014)
Mechanisms underlying mutational signatures in human cancers
Thomas Helleday et al.
NATURE REVIEWS GENETICS (2014)
Breast-Cancer Risk in Families with Mutations in PALB2
A. C. Antoniou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cancer Suppression by the Chromosome Custodians, BRCA1 and BRCA2
Ashok R. Venkitaraman
SCIENCE (2014)
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia
Amanda B. Spurdle et al.
BREAST CANCER RESEARCH (2014)
International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer
Marcia Irene Canto et al.
GUT (2013)
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
V. Abkevich et al.
BRITISH JOURNAL OF CANCER (2012)
Playing the End Game: DNA Double-Strand Break Repair Pathway Choice
J. Ross Chapman et al.
MOLECULAR CELL (2012)
BRCA1 and BRCA2: different roles in a common pathway of genome protection
Rohini Roy et al.
NATURE REVIEWS CANCER (2012)
The BRCA1-RAP80 Complex Regulates DNA Repair Mechanism Utilization by Restricting End Resection
Kara A. Coleman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Risk of Breast Cancer in Women With a CHEK2 Mutation With and Without a Family History of Breast Cancer
Cezary Cybulski et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Germline mutations in RAD51D confer susceptibility to ovarian cancer
Chey Loveday et al.
NATURE GENETICS (2011)
Mutations in BRIP1 confer high risk of ovarian cancer
Thorunn Rafnar et al.
NATURE GENETICS (2011)
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
Tom Walsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis
Mary Ellen Moynahan et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Linking the Cellular Functions of BRCA Genes to Cancer Pathogenesis and Treatment
Ashok R. Venkitaraman
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
NBA1, a new player in the Brca1 A complex, is required for DNA damage resistance and checkpoint control
Bin Wang et al.
GENES & DEVELOPMENT (2009)
BRCA Germline Mutations in Jewish Patients With Pancreatic Adenocarcinoma
Cristina R. Ferrone et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance
Elizabeth M. Swisher et al.
CANCER RESEARCH (2008)
Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families
Frederic Guenard et al.
JOURNAL OF HUMAN GENETICS (2008)
Resistance to therapy caused by intragenic deletion in BRCA2
Stacey L. Edwards et al.
NATURE (2008)
Molecular origins of cancer
Harold J. Burstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Molecular basis for estrogen receptor α deficiency in BRCA1-linked breast cancer
Alison M. Hosey et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response
Bin Wang et al.
SCIENCE (2007)
Meta-analysis of BRCA1 and BRCA2 penetrance
Sining Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer
Sarah Reid et al.
NATURE GENETICS (2007)
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
Nazneen Rahman et al.
NATURE GENETICS (2007)
Cancer risks among BRCA1 and BRCA2 mutation carriers
E. Levy-Lahad et al.
BRITISH JOURNAL OF CANCER (2007)
The CHEK2 gene and inherited breast cancer susceptibility
H. Nevanlinna et al.
ONCOGENE (2006)
Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland
J Steffen et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation
Amy Finch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2
Bing Xia et al.
MOLECULAR CELL (2006)
BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution
CX Deng
NUCLEIC ACIDS RESEARCH (2006)
The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J
M Levitus et al.
NATURE GENETICS (2005)
CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair
F Esashi et al.
NATURE (2005)
NBS1 is a prostate cancer susceptibility gene
C Cybulski et al.
CANCER RESEARCH (2004)
CHEK2 is a multiorgan cancer susceptibility gene
C Cybulski et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations
DA Levine et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints
H Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study
AC Antoniou et al.
GENETIC EPIDEMIOLOGY (2001)
The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation
R Hashizume et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
DNA double-strand breaks: signaling, repair and the cancer connection
KK Khanna et al.
NATURE GENETICS (2001)
BRCA2 is required for homology-directed repair of chromosomal breaks
ME Moynahan et al.
MOLECULAR CELL (2001)
分享论文
